Buscar
Mostrando ítems 91-100 de 941
Lipoprotein Lipase and PPAR Alpha Gene Polymorphisms, Increased Very-Low-Density Lipoprotein Levels, and Decreased High-Density Lipoprotein Levels as Risk Markers for the Development of Visceral Leishmaniasis by Leishmania infantum
(Hindawi Publishing Corporation, 2014-01-01)
In visceral leishmaniasis (VL) endemic areas, a minority of infected individuals progress to disease since most of them develop protective immunity. Therefore, we investigated the risk markers of VL within nonimmune sector. ...
Comparación del perfil lipídico por sexo y edad en ovinos
(Universidad Nacional de Colombia - Sede Bogotá - Facultad de Medicina Veterinaria y de Zootecnia, 2015-01-01)
Se comparó el perfil lipídico y la correlación entre los componentes lipídicos del suero en cuatro grupos de ovinos. A tal fin, se tomaron muestras de sangre de 98 ovinos en ayuno, diferenciados por género y edad (23 machos ...
Changes in HDL-c concentrations after 16 weeks of combined training in postmenopausal women: Characteristics of positive and negative responders
(2018-01-01)
This study aimed to investigate the individual characteristics of body composition and metabolic profile that could explain interindividual variation in high-density lipoprotein cholesterol (HDL-c) concentrations in response ...
Chronic treatment with a mild dose of NaF promotes dyslipidemia in rats
(2015-01-01)
Excessive fluoride ion (F) intake promotes systemic metabolic alterations, such as a decrease in insulin secretion, hyperglycemia, and insulin resistance, similar to those observed in diabetes. Cardiovascular disease is ...
Comparação do perfil clínico de crianças não obesas com apneia do sono e ronco
(Associação Brasileira de Otorrinolaringologia e Cirurgia Cervicofacial, 2012-10-01)
Few studies in the literature have looked into the cardiovascular and metabolic effects of Obstructive Sleep Apnea Syndrome (OSAS) in children. OBJECTIVE: This study aims to evaluate the metabolic profile of non-obese ...
Aspectos clínicos e metabólicos de mulheres na pós-menopausa tratadas com tibolona
(Federação Brasileira das Sociedades de Ginecologia e Obstetrícia, 2000-02-01)
Purpose: to evaluate the effects of tibolone on climacteric symptoms and clinical and metabolic variables. Methods: thirty-four postmenopausal women were treated orally with 2.5 mg tibolone daily for 48 weeks and evaluated ...